WEBINAR REPLAY: August 18, 2021
Welcome to the CEO Roadshow Webinar Series where we feature small and mid-cap stocks that may be undervalued or have other upcoming catalysts that make them a potential long-term investment opportunity.
In this episode, we’re joined by Rodney Varner, President, and CEO of Genprex.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, that trades on the NASDAQ under ticker GNPX.
CEOROADSHOW content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to the accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor.
Any opinions expressed in CEOROADSHOW content and productions, or other investor relations materials and presentations are subject to change. Neither CEOROADSHOW nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. All data and information are provided for informational or entertainment purposes only. CEOROADSHOW is not a registered broker-dealer or a registered investment advisor.
CEORoadshow.com is committed to providing our readers with useful information on publicly traded companies. CEORoadshow.com sometimes contracts with third parties or publicly traded companies and receives compensation from them in the form of cash as payment for publishing information and opinions about the company and the trading market for their securities.
CEORoadshow.com content should not be considered to be independent publications concerning the company. CEORoadshow was paid a fee by Genprex, Inc. for publication of this webinar and other video interviews.
Neither CEOROADSHOW.COM or any of its principals currently own or plan to own within 72 hours of publication any shares of the stocks mentioned in this video. For a full disclaimer please visit, CEOROADSHOW.COM/disclaimer.